Breaking News Instant updates and real-time market news.

WTER

Alkaline Water

$1.64 /

-0.07 (-4.11%)

09:06
08/12/20
08/12
09:06
08/12/20
09:06

Alkaline Water adds DSD distributor Mahaska to expand Midwest footprint

The Alkaline Water Company announces that The Alkaline Water Company's entire line of beverage offerings, including flavored waters, will be carried by Mahaska, a leading Direct-Store-Deliver provider in some of the major markets in the Midwest.

  • 13

    Aug

WTER Alkaline Water
$1.64 /

-0.07 (-4.11%)

07/24/20 H.C. Wainwright
Alkaline Water upgraded to Buy from Neutral at H.C. Wainwright
06/08/20 Roth Capital
Alkaline Water initiated with a Buy at Roth Capital
03/16/20 H.C. Wainwright
Alkaline Water downgraded to Neutral from Buy at H.C. Wainwright
08/28/19 H.C. Wainwright
Alkaline Water initiated with a Buy at H.C. Wainwright

TODAY'S FREE FLY STORIES

Downgrade
Aimco downgraded to Sell from Neutral at Citi » 06:13
09/18/20
09/18
06:13
09/18/20
06:13
AIV

Aimco

$36.36 /

-0.825 (-2.22%)

Citi analyst Nicholas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AIV Aimco
$36.36 /

-0.825 (-2.22%)

AIV Aimco
$36.36 /

-0.825 (-2.22%)

09/14/20 BofA
Aimco upgraded to Neutral at BofA after split announcement
09/14/20 BofA
Aimco upgraded to Neutral from Underperform at BofA
09/09/20
Fly Intel: Top five analyst downgrades
09/09/20 Goldman Sachs
Aimco downgraded to Neutral from Buy at Goldman Sachs
AIV Aimco
$36.36 /

-0.825 (-2.22%)

AIV Aimco
$36.36 /

-0.825 (-2.22%)

Syndicate
Essential Properties Realty Trust 8M share Spot Secondary priced at $19.00 » 06:12
09/18/20
09/18
06:12
09/18/20
06:12
EPRT

Essential Properties Realty Trust

$19.84 /

-0.28 (-1.39%)

The deal range was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EPRT Essential Properties Realty Trust
$19.84 /

-0.28 (-1.39%)

EPRT Essential Properties Realty Trust
$19.84 /

-0.28 (-1.39%)

07/02/20 Citi
Essential Properties Realty Trust price target raised to $15 from $10 at Citi
06/08/20 Evercore ISI
Essential Properties upgraded to Outperform from In Line at Evercore ISI
04/16/20 Scotiabank
Essential Properties downgraded to Sector Perform from Outperform at Scotiabank
04/07/20 Citi
Essential Properties Realty Trust price target lowered to $10 from $26 at Citi
EPRT Essential Properties Realty Trust
$19.84 /

-0.28 (-1.39%)

  • 18
    Sep
  • 10
    Jan
Initiation
Intellia Therapeutics initiated with a Buy at Goldman Sachs » 06:11
09/18/20
09/18
06:11
09/18/20
06:11
NTLA

Intellia Therapeutics

$22.44 /

-0.52 (-2.26%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$22.44 /

-0.52 (-2.26%)

NTLA Intellia Therapeutics
$22.44 /

-0.52 (-2.26%)

08/20/20 Chardan
Intellia Therapeutics nearing an inflection point, says Chardan
06/01/20 Wedbush
Intellia Therapeutics price target raised to $20 from $16 at Wedbush
02/28/20 Oppenheimer
Intellia making progress in in-vivo editing, says Oppenheimer
02/14/20 Wedbush
Intellia Therapeutics downgraded to Neutral from Outperform at Wedbush
NTLA Intellia Therapeutics
$22.44 /

-0.52 (-2.26%)

  • 03
    Jun
NTLA Intellia Therapeutics
$22.44 /

-0.52 (-2.26%)

Periodicals
GNC Holdings wins court approval for sale to China's Harbin, WSJ reports » 06:10
09/18/20
09/18
06:10
09/18/20
06:10
GNC

GNC Holdings

$0.00 /

+ (+0.00%)

GNC has won court…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GNC GNC Holdings
$0.00 /

+ (+0.00%)

GNC GNC Holdings
$0.00 /

+ (+0.00%)

03/17/20 Jefferies
Jefferies cuts GNC Holdings to Underperform on risk from closures and debt
03/17/20 Jefferies
GNC Holdings downgraded to Underperform from Hold at Jefferies
GNC GNC Holdings
$0.00 /

+ (+0.00%)

GNC GNC Holdings
$0.00 /

+ (+0.00%)

GNC GNC Holdings
$0.00 /

+ (+0.00%)

Recommendations
Cheesecake Factory price target raised to $38 from $30 at Piper Sandler » 06:08
09/18/20
09/18
06:08
09/18/20
06:08
CAKE

Cheesecake Factory

$29.32 /

-1.725 (-5.56%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CAKE Cheesecake Factory
$29.32 /

-1.725 (-5.56%)

CAKE Cheesecake Factory
$29.32 /

-1.725 (-5.56%)

08/03/20 BofA
Cheesecake Factory downgraded to Underperform from Neutral at BofA
07/09/20 Credit Suisse
Cheesecake Factory initiated with a Neutral at Credit Suisse
07/01/20 Gordon Haskett
Cheesecake Factory downgraded to Hold as reopenings pause at Gordon Haskett
07/01/20 Gordon Haskett
Cheesecake Factory downgraded to Hold from Buy at Gordon Haskett
CAKE Cheesecake Factory
$29.32 /

-1.725 (-5.56%)

CAKE Cheesecake Factory
$29.32 /

-1.725 (-5.56%)

CAKE Cheesecake Factory
$29.32 /

-1.725 (-5.56%)

CAKE Cheesecake Factory
$29.32 /

-1.725 (-5.56%)

Initiation
Intuit initiated with an Overweight at Piper Sandler » 06:07
09/18/20
09/18
06:07
09/18/20
06:07
INTU

Intuit

$307.15 /

-6.325 (-2.02%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INTU Intuit
$307.15 /

-6.325 (-2.02%)

INTU Intuit
$307.15 /

-6.325 (-2.02%)

08/27/20 Argus
Intuit price target raised to $400 from $325 at Argus
08/26/20 RBC Capital
Intuit price target raised to $405 from $315 at RBC Capital
08/26/20 Oppenheimer
Intuit price target raised to $355 from $308 at Oppenheimer
08/26/20 Guggenheim
Intuit price target raised to $395 from $320 at Guggenheim
INTU Intuit
$307.15 /

-6.325 (-2.02%)

INTU Intuit
$307.15 /

-6.325 (-2.02%)

INTU Intuit
$307.15 /

-6.325 (-2.02%)

Hot Stocks
PG&E CFO Jason Wells resigns to become CFO of another utility » 06:07
09/18/20
09/18
06:07
09/18/20
06:07
PCG

PG&E

$9.79 /

-0.02 (-0.20%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCG PG&E
$9.79 /

-0.02 (-0.20%)

PCG PG&E
$9.79 /

-0.02 (-0.20%)

08/03/20 Mizuho
PG&E price target raised to $14.50 from $13.50 at Mizuho
07/28/20 Citi
PG&E shares look inexpensive into wildfire season, says Citi
07/26/20 Goldman Sachs
PG&E resumed with a Buy at Goldman Sachs
07/09/20 Mizuho
PG&E trading at 56% price-to-earnings discount, says Mizuho
PCG PG&E
$9.79 /

-0.02 (-0.20%)

  • 26
    Jun
PCG PG&E
$9.79 /

-0.02 (-0.20%)

PCG PG&E
$9.79 /

-0.02 (-0.20%)

PCG PG&E
$9.79 /

-0.02 (-0.20%)

Initiation
BioLife Solutions initiated with an Outperform at Cowen » 06:06
09/18/20
09/18
06:06
09/18/20
06:06
BLFS

BioLife Solutions

$25.38 /

-0.42 (-1.63%)

Cowen analyst Chris Lin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BLFS BioLife Solutions
$25.38 /

-0.42 (-1.63%)

BLFS BioLife Solutions
$25.38 /

-0.42 (-1.63%)

08/11/20 Benchmark
BioLife Solutions downgraded at Benchmark as shares reach price target
08/11/20 Benchmark
BioLife Solutions downgraded to Hold from Buy at Benchmark
07/10/20 B. Riley FBR
BioLife Solutions price target raised to $25.50 from $20 at B. Riley FBR
07/08/20 Northland
BioLife Solutions price target raised to $28 from $24 at Northland
BLFS BioLife Solutions
$25.38 /

-0.42 (-1.63%)

  • 02
    Jul
BLFS BioLife Solutions
$25.38 /

-0.42 (-1.63%)

Periodicals
SoftBank selling Brightstar to private equity firm, WSJ reports » 06:05
09/18/20
09/18
06:05
09/18/20
06:05
SFTBY

SoftBank

$0.00 /

+ (+0.00%)

SoftBank is selling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SFTBY SoftBank
$0.00 /

+ (+0.00%)

SFTBY SoftBank
$0.00 /

+ (+0.00%)

09/15/20 Craig-Hallum
Nvidia price target raised to $500 from $480 at Craig-Hallum
09/15/20 Oppenheimer
Nvidia's acquisition of ARM strengthens AI hand, says Oppenheimer
09/14/20 Deutsche Bank
ARM customers could push back on Nvidia deal, says Deutsche Bank
09/14/20 RBC Capital
RBC Capital sees ARM Holdings deal as positive for Nvidia, negative for Intel
SFTBY SoftBank
$0.00 /

+ (+0.00%)

SFTBY SoftBank
$0.00 /

+ (+0.00%)

Hot Stocks
Power REIT acquires Maine property for cannabis processing » 06:05
09/18/20
09/18
06:05
09/18/20
06:05
PW

Power REIT

$17.91 /

-1.32 (-6.86%)

Power REIT announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PW Power REIT
$17.91 /

-1.32 (-6.86%)

Initiation
Epiroc initiated with a Buy at Berenberg » 06:03
09/18/20
09/18
06:03
09/18/20
06:03
EPOKY

Epiroc

$0.00 /

+ (+0.00%)

Berenberg analyst Joel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EPOKY Epiroc
$0.00 /

+ (+0.00%)

07/24/20 JPMorgan
Epiroc price target raised to SEK 115 from SEK 105 at JPMorgan
07/24/20 Deutsche Bank
Epiroc price target raised to SEK 120 from SEK 105 at Deutsche Bank
07/24/20 Credit Suisse
Epiroc price target raised to SEK 105 from SEK 88 at Credit Suisse
07/24/20 UBS
UBS backs Buy on Epiroc after Q2 results
Hot Stocks
Incyte says retifanlimab 'generally well-tolerated' in Phase 2 trial » 06:02
09/18/20
09/18
06:02
09/18/20
06:02
INCY

Incyte

$90.32 /

+0.39 (+0.43%)

Incyte announced results…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INCY Incyte
$90.32 /

+0.39 (+0.43%)

INCY Incyte
$90.32 /

+0.39 (+0.43%)

04:57 Today Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/14/20 Mizuho
Oncology 'fertile ground for M&A activity,' says Mizuho
08/05/20 Mizuho
Incyte price target raised to $95 from $79 at Mizuho
08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
INCY Incyte
$90.32 /

+0.39 (+0.43%)

INCY Incyte
$90.32 /

+0.39 (+0.43%)

INCY Incyte
$90.32 /

+0.39 (+0.43%)

Periodicals
ByteDance, Oracle deal includes creation of oversight board, Axios reports » 06:01
09/18/20
09/18
06:01
09/18/20
06:01
ORCL

Oracle

$60.20 /

-0.23 (-0.38%)

An agreement between…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ORCL Oracle
$60.20 /

-0.23 (-0.38%)

ORCL Oracle
$60.20 /

-0.23 (-0.38%)

09/14/20 Wells Fargo
Oracle deal with TikTok looks like 'win-win,' says Wells Fargo
09/11/20 Societe Generale
Oracle price target raised to $70 from $60 at Societe Generale
09/11/20 RBC Capital
Oracle price target raised to $60 from $51 at RBC Capital
09/11/20 BMO Capital
Oracle price target raised to $63 from $57 at BMO Capital
ORCL Oracle
$60.20 /

-0.23 (-0.38%)

ORCL Oracle
$60.20 /

-0.23 (-0.38%)

ORCL Oracle
$60.20 /

-0.23 (-0.38%)

ORCL Oracle
$60.20 /

-0.23 (-0.38%)

Downgrade
JPMorgan downgrades Beyond Meat to Underweight on 'sluggish' fundamentals » 06:01
09/18/20
09/18
06:01
09/18/20
06:01
BYND

Beyond Meat

$157.27 /

+0.49 (+0.31%)

JPMorgan analyst Ken…

JPMorgan analyst Ken Goldman downgraded Beyond Meat to Underweight from Neutral with an unchanged price target of $122. The shares closed Thursday up 65c to $157.22. The stock's 108% rally year-to-date is "above and beyond what we consider rational," even for a good company like Beyond Meat, Goldman tells investors in a research note. Street estimates look high with chief rival Impossible Foods taking market share at grocery and restaurants hesitating to add menu complexity during the COVID-19 crisis, adds the analyst. Goldman cites valuation and "sluggish fundamentals" for the downgrade.

ShowHide Related Items >><<
BYND Beyond Meat
$157.27 /

+0.49 (+0.31%)

BYND Beyond Meat
$157.27 /

+0.49 (+0.31%)

04:44 Today JPMorgan
Beyond Meat downgraded to Underweight from Neutral at JPMorgan
09/15/20 Credit Suisse
Beyond Meat sales growth capped by near-term factors, says Credit Suisse
09/03/20
Fly Intel: Top five analyst initiations
09/02/20 Baird
Baird starts Beyond Meat at Outperform with $160 price target
BYND Beyond Meat
$157.27 /

+0.49 (+0.31%)

BYND Beyond Meat
$157.27 /

+0.49 (+0.31%)

BYND Beyond Meat
$157.27 /

+0.49 (+0.31%)

BYND Beyond Meat
$157.27 /

+0.49 (+0.31%)

Periodicals
JD.com's JD Health plans $1B Hong Kong IPO, Bloomberg reports » 05:59
09/18/20
09/18
05:59
09/18/20
05:59
JD

JD.com

$74.38 /

-0.68 (-0.91%)

, BAC

Bank of America

$25.35 /

-0.265 (-1.03%)

, UBS

UBS

$12.27 /

-0.075 (-0.61%)

JD Health, the online…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JD JD.com
$74.38 /

-0.68 (-0.91%)

BAC Bank of America
$25.35 /

-0.265 (-1.03%)

UBS UBS
$12.27 /

-0.075 (-0.61%)

JD JD.com
$74.38 /

-0.68 (-0.91%)

08/24/20 Barclays
JD.com price target raised to $83 from $79 at Barclays
08/18/20
Fly Intel: Top five analyst upgrades
08/18/20 Susquehanna
JD.com price target raised to $70 from $55 at Susquehanna
08/18/20 Stifel
JD.com price target raised to $70 from $60 at Stifel
BAC Bank of America
$25.35 /

-0.265 (-1.03%)

09/03/20 Deutsche Bank
Bank of America upgraded to Buy from Hold at Deutsche Bank
07/09/20 DA Davidson
Bank of America downgraded to Neutral from Buy at DA Davidson
07/08/20
Fly Intel: Top five analyst initiations
07/08/20 Seaport Global
Bank of America initiated with a Neutral at Seaport Global
UBS UBS
$12.27 /

-0.075 (-0.61%)

07/24/20 Morgan Stanley
UBS price target raised to CHF 12 from CHF 11 at Morgan Stanley
07/23/20 Oddo BHF
UBS upgraded to Neutral from Reduce at Oddo BHF
07/22/20 Credit Suisse
UBS price target raised to CHF 14.50 from CHF 14 at Credit Suisse
07/22/20 RBC Capital
UBS price target raised to CHF 12 from CHF 11 at RBC Capital
JD JD.com
$74.38 /

-0.68 (-0.91%)

BAC Bank of America
$25.35 /

-0.265 (-1.03%)

UBS UBS
$12.27 /

-0.075 (-0.61%)

JD JD.com
$74.38 /

-0.68 (-0.91%)

BAC Bank of America
$25.35 /

-0.265 (-1.03%)

UBS UBS
$12.27 /

-0.075 (-0.61%)

JD JD.com
$74.38 /

-0.68 (-0.91%)

BAC Bank of America
$25.35 /

-0.265 (-1.03%)

UBS UBS
$12.27 /

-0.075 (-0.61%)

JD JD.com
$74.38 /

-0.68 (-0.91%)

BAC Bank of America
$25.35 /

-0.265 (-1.03%)

Hot Stocks
Ericsson acquires Cradlepoint in deal valued at 1.1B » 05:57
09/18/20
09/18
05:57
09/18/20
05:57
ERIC

Ericsson

$11.03 /

+0.165 (+1.52%)

Ericsson said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ERIC Ericsson
$11.03 /

+0.165 (+1.52%)

ERIC Ericsson
$11.03 /

+0.165 (+1.52%)

08/26/20 Citi
Ericsson sell-side briefing supportive of positive thesis, says Citi
07/28/20 Raymond James
Corning results provide read-through to optical names, says Raymond James
07/20/20 JPMorgan
Ericsson price target raised to SEK 110 from SEK 104 at JPMorgan
07/20/20 Morgan Stanley
Ericsson price target raised to SEK 110 from SEK 100 at Morgan Stanley
ERIC Ericsson
$11.03 /

+0.165 (+1.52%)

ERIC Ericsson
$11.03 /

+0.165 (+1.52%)

ERIC Ericsson
$11.03 /

+0.165 (+1.52%)

ERIC Ericsson
$11.03 /

+0.165 (+1.52%)

Hot Stocks
Genentech announces Phase III EMPACTA study met primary endpoint » 05:53
09/18/20
09/18
05:53
09/18/20
05:53
RHHBY

Roche

$0.00 /

+ (+0.00%)

Genentech, a member of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
08/18/20 Morgan Stanley
Roche price target raised to CHF 372 from CHF 370 at Morgan Stanley
07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Hot Stocks
CaixaBank to acquire Bankia for exchange ratio of 0.6845 shares » 05:40
09/18/20
09/18
05:40
09/18/20
05:40
CAIXY

CaixaBank

$0.00 /

+ (+0.00%)

, BNKXF

Bankia

$0.00 /

+ (+0.00%)

The boards of Directors…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CAIXY CaixaBank
$0.00 /

+ (+0.00%)

09/07/20 Berenberg
CaixaBank upgraded to Hold from Sell at Berenberg
08/07/20 AlphaValue
CaixaBank upgraded to Buy from Reduce at AlphaValue
08/03/20 Deutsche Bank
CaixaBank price target lowered to EUR 2.55 from EUR 2.60 at Deutsche Bank
08/03/20 Credit Suisse
CaixaBank positive investment thesis intact after Q2, says Credit Suisse
BNKXF Bankia
$0.00 /

+ (+0.00%)

09/16/20 Barclays
Bankia price target raised to EUR 1.30 from EUR 1.20 at Barclays
09/16/20 Citi
Bankia downgraded to Neutral from Buy at Citi
09/07/20 Berenberg
Bankia upgraded to Hold from Sell at Berenberg
09/04/20 Exane BNP Paribas
Bankia upgraded to Neutral from Underperform at Exane BNP Paribas
CAIXY CaixaBank
$0.00 /

+ (+0.00%)

BNKXF Bankia
$0.00 /

+ (+0.00%)

Hot Stocks
NetEase announces ADS ratio change of five-for-one » 05:32
09/18/20
09/18
05:32
09/18/20
05:32
NTES

NetEase

$469.85 /

-4.44 (-0.94%)

NetEase announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTES NetEase
$469.85 /

-4.44 (-0.94%)

NTES NetEase
$469.85 /

-4.44 (-0.94%)

08/14/20 Barclays
NetEase price target raised to $530 from $500 at Barclays
08/14/20 Daiwa
NetEase initiated with a Buy at Daiwa
08/14/20 Benchmark
NetEase price target raised to $520 from $435 at Benchmark
07/27/20 Barclays
NetEase price target raised to $500 from $450 at Barclays
NTES NetEase
$469.85 /

-4.44 (-0.94%)

NTES NetEase
$469.85 /

-4.44 (-0.94%)

NTES NetEase
$469.85 /

-4.44 (-0.94%)

NTES NetEase
$469.85 /

-4.44 (-0.94%)

Hot Stocks
Akcea Therapeutics receives NICE recommendation for volanesorsen » 05:27
09/18/20
09/18
05:27
09/18/20
05:27
AKCA

Akcea Therapeutics

$18.15 /

-0.005 (-0.03%)

Akcea Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKCA Akcea Therapeutics
$18.15 /

-0.005 (-0.03%)

AKCA Akcea Therapeutics
$18.15 /

-0.005 (-0.03%)

09/01/20 Oppenheimer
Ionis Pharmaceuticals price target lowered to $69 from $74 at Oppenheimer
08/31/20 BMO Capital
Akcea Therapeutics downgraded to Market Perform from Outperform at BMO Capital
08/31/20 Wells Fargo
Akcea Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
08/31/20 Piper Sandler
Piper Sandler sees Akcea consolidation as rational, cost 'appears minor'
AKCA Akcea Therapeutics
$18.15 /

-0.005 (-0.03%)

AKCA Akcea Therapeutics
$18.15 /

-0.005 (-0.03%)

Hot Stocks
Pfizer, EMD Serono announce publication of JAVELIN Bladder 100 study results » 05:20
09/18/20
09/18
05:20
09/18/20
05:20
PFE

Pfizer

$36.81 /

+0.02 (+0.05%)

EMD Serono and Pfizer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$36.81 /

+0.02 (+0.05%)

PFE Pfizer
$36.81 /

+0.02 (+0.05%)

09/16/20 Baird
uniQure weakness a buying opportunity, says Baird
09/15/20 Citi
Sarepta price target raised to $190 from $177 at Citi
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/09/20 JMP Securities
Trillium Therapeutics price target raised to $14 from $10 at JMP Securities
PFE Pfizer
$36.81 /

+0.02 (+0.05%)

PFE Pfizer
$36.81 /

+0.02 (+0.05%)

PFE Pfizer
$36.81 /

+0.02 (+0.05%)

PFE Pfizer
$36.81 /

+0.02 (+0.05%)

Hot Stocks
Apple brings online store to India September 23 » 05:20
09/18/20
09/18
05:20
09/18/20
05:20
AAPL

Apple

$110.35 /

-1.72 (-1.53%)

Apple said in a release,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$110.35 /

-1.72 (-1.53%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

09/17/20 BWS Financial
AXT rumors of Apple win highlight value, says BWS Financial
09/17/20 Jefferies
Apple price target raised to $135 from $116.25 at Jefferies
09/16/20 B. Riley FBR
AXT Inc. shares may be overreacting to Apple Watch 6 news, says B. Riley FBR
09/16/20 Wedbush
Focus remains Apple iPhone 12 5G 'supercycle,' says Wedbush
AAPL Apple
$110.35 /

-1.72 (-1.53%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

General news
FX Action: The is up on safe demand » 05:20
09/18/20
09/18
05:20
09/18/20
05:20

FX Action: The is up on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Zalando upgraded to Conviction Buy from Buy at Bryan Garnier » 05:19
09/18/20
09/18
05:19
09/18/20
05:19
ZLNDY

Zalando

$0.00 /

+ (+0.00%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZLNDY Zalando
$0.00 /

+ (+0.00%)

09/14/20 AlphaValue
Zalando upgraded to Add from Sell at AlphaValue
09/03/20 Barclays
Zalando price target raised to EUR 78.30 from EUR 65.50 at Barclays
08/31/20 Goldman Sachs
Zalando upgraded to Buy from Neutral at Goldman Sachs
08/12/20 RBC Capital
Zalando price target raised to EUR 80 from EUR 73 at RBC Capital
Hot Stocks
Regeneron, Sanofi present 'positive' data for Libtayo monotherapy in BCC » 05:19
09/18/20
09/18
05:19
09/18/20
05:19
REGN

Regeneron

$564.85 /

-4.15 (-0.73%)

, SNY

Sanofi

$52.08 /

+0.21 (+0.40%)

Regeneron Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$564.85 /

-4.15 (-0.73%)

SNY Sanofi
$52.08 /

+0.21 (+0.40%)

REGN Regeneron
$564.85 /

-4.15 (-0.73%)

09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/10/20 Benchmark
Vaccine may be approved before Regeneron's COVID therapeutic, says Benchmark
09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
SNY Sanofi
$52.08 /

+0.21 (+0.40%)

09/14/20 Roth Capital
Immunic has 'significant' opportunity in RRMS, says Roth Capital
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/19/20 Stifel
Principia Biopharma downgraded to Hold from Buy at Stifel
08/18/20 SVB Leerink
Principia Biopharma downgraded to Market Perform at SVB Leerink
REGN Regeneron
$564.85 /

-4.15 (-0.73%)

SNY Sanofi
$52.08 /

+0.21 (+0.40%)

  • 27
    May
REGN Regeneron
$564.85 /

-4.15 (-0.73%)

SNY Sanofi
$52.08 /

+0.21 (+0.40%)

REGN Regeneron
$564.85 /

-4.15 (-0.73%)

SNY Sanofi
$52.08 /

+0.21 (+0.40%)

REGN Regeneron
$564.85 /

-4.15 (-0.73%)

SNY Sanofi
$52.08 /

+0.21 (+0.40%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.